These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28554417)

  • 1. New Symptomatic Treatments for the Management of Motor and Nonmotor Symptoms of Parkinson's Disease.
    Taddei RN; Spinnato F; Jenner P
    Int Rev Neurobiol; 2017; 132():407-452. PubMed ID: 28554417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease.
    Titova N; Chaudhuri KR
    Int Rev Neurobiol; 2017; 134():1257-1281. PubMed ID: 28805572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact and management of nonmotor symptoms of Parkinson's disease.
    Lyons KE; Pahwa R
    Am J Manag Care; 2011 Oct; 17 Suppl 12():S308-14. PubMed ID: 22087551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson's Disease.
    Jing XZ; Yuan XZ; Luo X; Zhang SY; Wang XP
    Curr Neuropharmacol; 2023; 21(8):1806-1826. PubMed ID: 35193486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.
    Martinez-Martin P; Reddy P; Katzenschlager R; Antonini A; Todorova A; Odin P; Henriksen T; Martin A; Calandrella D; Rizos A; Bryndum N; Glad A; Dafsari HS; Timmermann L; Ebersbach G; Kramberger MG; Samuel M; Wenzel K; Tomantschger V; Storch A; Reichmann H; Pirtosek Z; Trost M; Svenningsson P; Palhagen S; Volkmann J; Chaudhuri KR
    Mov Disord; 2015 Apr; 30(4):510-6. PubMed ID: 25382161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of Parkinson disease: a review.
    Connolly BS; Lang AE
    JAMA; 2014 Apr 23-30; 311(16):1670-83. PubMed ID: 24756517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease--Part 2: Treatment of motor symptoms.
    Weintraub D; Comella CL; Horn S
    Am J Manag Care; 2008 Mar; 14(2 Suppl):S49-58. PubMed ID: 18402508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targets for treating the underlying pathophysiology and nonmotor aspects of Parkinson's disease.
    Butler JT; Tolleson C
    CNS Neurol Disord Drug Targets; 2014; 13(7):1273-9. PubMed ID: 25230233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms.
    Snyder CH; Adler CH
    J Am Acad Nurse Pract; 2007 Apr; 19(4):179-97. PubMed ID: 17430539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapies in Parkinson's disease.
    Jankovic J; Poewe W
    Curr Opin Neurol; 2012 Aug; 25(4):433-47. PubMed ID: 22691758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease.
    Isaacson SH
    J Clin Psychiatry; 2020 Jan; 81(1):. PubMed ID: 31917910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced Parkinson's disease.
    Giugni JC; Okun MS
    Curr Opin Neurol; 2014 Aug; 27(4):450-60. PubMed ID: 24978634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the behavioral aspects of Parkinson's disease.
    Borek LL; Chou KL; Friedman JH
    Expert Rev Neurother; 2007 Jun; 7(6):711-25. PubMed ID: 17563253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current strategies in the treatment of Parkinson's disease and a personalized approach to management.
    Diaz NL; Waters CH
    Expert Rev Neurother; 2009 Dec; 9(12):1781-9. PubMed ID: 19951137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for Parkinson disease--past achievements and current clinical needs.
    Poewe W
    Neurology; 2009 Feb; 72(7 Suppl):S65-73. PubMed ID: 19221317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing the neuropsychiatric symptoms of Parkinson's disease.
    Lieberman A
    Neurology; 1998 Jun; 50(6 Suppl 6):S33-8; discussion S44-8. PubMed ID: 9633685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease psychosis: presentation, diagnosis and management.
    Schneider RB; Iourinets J; Richard IH
    Neurodegener Dis Manag; 2017 Dec; 7(6):365-376. PubMed ID: 29160144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sleep disturbances in Parkinson's disease: characteristics, evaluation and therapeutic approaches].
    Faludi B; Janszky J; Komoly S; Kovács N
    Orv Hetil; 2015 Jul; 156(27):1091-9. PubMed ID: 26122904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in therapeutic strategies for Parkinson's disease.
    Kulisevsky J; Oliveira L; Fox SH
    Curr Opin Neurol; 2018 Aug; 31(4):439-447. PubMed ID: 29746402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.